Mesothelioma screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(8 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Mesothelioma}}
{{Mesothelioma}}
{{CMG}}
{{CMG}}{{AE}}{{FA}}{{PSD}}
==Overview==
==Overview==
There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for mesothelioma.
== Screening ==
== Screening ==
There is no universally agreed protocol for screening people who have been exposed to asbestos. However some research indicates that the [[blood plasma|serum]] [[osteopontin]] level might be useful in screening asbestos-exposed people for mesothelioma. The level of soluble mesothelin-related protein is elevated in the serum of about 75% of patients at diagnosis and it has been suggested that it may be useful for screening.<ref name="smrp">"Soluble mesothelin-related protein--a blood test for mesothelioma" by B. W. Robinson, J. Creaney, R. Lake, A. Nowak, A. W. Musk, N. de Klerk, P. Winzell, K. E. Hellstrom and I. Hellstrom in ''Lung Cancer'' (2005) volume 49, pages S109-S111 {{Entrez Pubmed|15950789}}.</ref>
*There is no universally agreed protocol for [[Screening (medicine)|screening]] people who have been exposed to [[asbestos]].  
*However some research indicates that the [[osteopontin|serum osteopontin]] level might be useful in [[Screening (medicine)|screening]] [[asbestos]]-exposed people for mesothelioma.  
*The level of soluble mesothelin-related protein is elevated in the [[serum]] of about 75% of patients at diagnosis and it has been suggested that it may be useful for [[Screening (medicine)|screening]].<ref name="smrp">"Soluble mesothelin-related protein--a blood test for mesothelioma" by B. W. Robinson, J. Creaney, R. Lake, A. Nowak, A. W. Musk, N. de Klerk, P. Winzell, K. E. Hellstrom and I. Hellstrom in ''Lung Cancer'' (2005) volume 49, pages S109-S111 {{Entrez Pubmed|15950789}}.</ref>


==References==
==References==
Line 17: Line 20:
[[Category:Asbestos]]
[[Category:Asbestos]]
[[Category:Occupational diseases]]
[[Category:Occupational diseases]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Medicine]]

Latest revision as of 16:15, 25 April 2018

Mesothelioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mesothelioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Summary of Treatment for Pleural Mesothelioma

Summary of Treatment for Peritoneal Mesothelioma

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mesothelioma screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mesothelioma screening

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mesothelioma screening

CDC on Mesothelioma screening

Mesothelioma screening in the news

Blogs on Mesothelioma screening

Directions to Hospitals Treating Mesothelioma

Risk calculators and risk factors for Mesothelioma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fatima Shaukat, MD [2]Parminder Dhingra, M.D. [3]

Overview

There is insufficient evidence to recommend routine screening for mesothelioma.

Screening

  • There is no universally agreed protocol for screening people who have been exposed to asbestos.
  • However some research indicates that the serum osteopontin level might be useful in screening asbestos-exposed people for mesothelioma.
  • The level of soluble mesothelin-related protein is elevated in the serum of about 75% of patients at diagnosis and it has been suggested that it may be useful for screening.[1]

References

  1. "Soluble mesothelin-related protein--a blood test for mesothelioma" by B. W. Robinson, J. Creaney, R. Lake, A. Nowak, A. W. Musk, N. de Klerk, P. Winzell, K. E. Hellstrom and I. Hellstrom in Lung Cancer (2005) volume 49, pages S109-S111 Template:Entrez Pubmed.


Template:WikiDoc Sources